Enliven Therapeutics, Inc.
SEC Filing List
ELVN CIK: 0001672619
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Hohl Benjamin | Enliven Therapeutics, Inc. | 08/19/2026 | |
| 4 | Statement of changes in beneficial owner... | Collins Helen Louise | Enliven Therapeutics, Inc. | 08/19/2026 | |
| SCHEDULE 13G/A | 08/06/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Derynck Mika K | Enliven Therapeutics, Inc. | 08/06/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Enliven Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/05/2026 | |
| 8-K | Current report filing | Enliven Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/05/2026 | |
| 144 | Filing for proposed sale of securities u... | JEFFERIES LLC/FA | 08/04/2026 | ||
| 4 | Statement of changes in beneficial owner... | Hohl Benjamin | Enliven Therapeutics, Inc. | 07/21/2026 | |
| 4 | Statement of changes in beneficial owner... | Collins Helen Louise | Enliven Therapeutics, Inc. | 07/21/2026 | |
| 144 | Filing for proposed sale of securities u... | JEFFERIES LLC/FA | 07/17/2026 | ||
| No record found. | |||||
| Load More | |||||
